" class="no-js "lang="en-US"> Muna Therapeutics - Medtech Alert
Saturday, September 13, 2025
Muna Therapeutics | Pharmtech Focus

Muna Therapeutics

About Muna Therapeutics

Muna Therapeutics

Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe.

We focus our groundbreaking science on identifying new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases.

Our name reflects this focus: Muna means ‘to remember’ in Old Norse.

Meet our Team

Related Story

Muna Therapeutics Appoints Dr. Niels Plath as Chief Scientific Officer

November 1 2021

Muna Therapeutics (“Muna“), pioneering the development of novel, first-in-class small molecule therapeutics for neurodegenerative diseases, […]

Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

July 9 2021

Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today […]